TrialLeukemia2013

Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.

D J DeAngelo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.